Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab

• Main Authors: Di Cao (Author), Chunping Deng (Author), Guangying Wang (Author), Xiong Mei (Author), Jianhua Xie (Author), Yuanmei Liu (Author), Yujie Liu (Author), Yili Yang (Author), Shengfeng Li (Author), Cuihua Liu (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2023-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background BAT1706 is a proposed biosimilar of bevacizumab, a vascular endothelial growth factor A (VEGF-A)-targeting biologic used to treat several different cancers, including metastatic colorectal cancer. A comprehensive physicochemical and functional similarity assessment is a key compo...